Excess winter mortality and morbidity before, during, and after the Great Recession: the Portuguese case.

Economic crisis Excess winter morbidity Excess winter mortality Great Recession

Journal

International journal of biometeorology
ISSN: 1432-1254
Titre abrégé: Int J Biometeorol
Pays: United States
ID NLM: 0374716

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 26 07 2018
accepted: 18 02 2019
revised: 07 02 2019
pubmed: 9 3 2019
medline: 12 10 2019
entrez: 9 3 2019
Statut: ppublish

Résumé

Although winter mortality and morbidity are phenomena common to most European countries, their magnitude varies significantly from country to country. The geographical disparities among regions with similar climates are the result of several social, economic, demographic, and biological conditions that influence an individual's vulnerability to winter conditions. The impact of poor socioeconomic conditions may be of such magnitude that an economic recession may aggravate the seasonal mortality pattern. This paper aims to measure the seasonal winter mortality, morbidity, and their related costs during the Great Recession (2009-2012) in mainland Portugal and its Regional Health Administrations (RHAs) and to compare it with the periods preceding and following it. Monthly mortality and morbidity data were collected and clustered into three periods: Great Recession (2009-2012), Pre-Recession (2005-2008), and Post-Recession (2013-2016). The impact of seasonal winter mortality and morbidity during the Great Recession in Portugal and its Regional Health Administrations was measured through the assessment of age-standardized excess winter (EW) death and hospital admissions rate and index, expected life expectancy gains without EW deaths, EW rate of potential years of life lost, and EW rate of emergency hospital admission costs. Important increases of winter deaths and hospital admissions were identified, resulting in an important number of potential years of life lost (87 years of life lost per 100,000 inhabitants in 2009-2012), life expectancy loss (1 year in 2009-2012), and National Health Service costs with explicit temporal and spatial variations. These human and economic costs have decreased consistently during the analyzed periods, while no significant increase was found during the Great Recession. Despite its reduction, the winter excess morbidity and mortality highlight that Portugal still faces substantial challenges related to a highly vulnerable population, calling for investments in better social and health protection.

Identifiants

pubmed: 30847575
doi: 10.1007/s00484-019-01700-6
pii: 10.1007/s00484-019-01700-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-883

Subventions

Organisme : Portuguese national funding agency for science, research and technology
ID : SFRH/BD/92568/2013

Références

Environ Res. 2003 May;92(1):8-13
pubmed: 12706750
J Epidemiol Community Health. 2003 Oct;57(10):784-9
pubmed: 14573581
Public Health. 2004 Apr;118(3):167-76
pubmed: 15003406
J R Soc Promot Health. 2005 Jan;125(1):18-22
pubmed: 15712848
J Public Health (Oxf). 2005 Dec;27(4):353-8
pubmed: 16155051
Occup Environ Med. 2007 Feb;64(2):93-100
pubmed: 16990293
BMC Public Health. 2007 Sep 24;7:263
pubmed: 17892590
Prev Chronic Dis. 2010 Jul;7(4):A71
pubmed: 20550829
J Epidemiol Community Health. 2012 Apr;66(4):379-84
pubmed: 20961875
BMJ. 2011 May 11;342:d2807
pubmed: 21562001
Maturitas. 2011 Jul;69(3):197-202
pubmed: 21592693
J Am Med Dir Assoc. 2012 Mar;13(3):309.e1-7
pubmed: 21764645
Public Health. 2012 Sep;126 Suppl 1:S4-S10
pubmed: 22784581
Eur Respir J. 2013 May;41(5):1141-6
pubmed: 22878871
Lancet. 2013 Apr 13;381(9874):1323-31
pubmed: 23541059
J Epidemiol Community Health. 2014 Jan;68(1):44-50
pubmed: 24101166
PLoS One. 2013 Oct 08;8(10):e77150
pubmed: 24116214
J Epidemiol Community Health. 2014 Mar;68(3):280-2
pubmed: 24153246
Gac Sanit. 2014 Jun;28 Suppl 1:137-41
pubmed: 24864003
Eur J Public Health. 2015 Apr;25(2):339-45
pubmed: 24919695
Health Policy. 2015 Mar;119(3):307-15
pubmed: 25583679
Health Policy. 2015 Jul;119(7):941-53
pubmed: 25979416
Int J Equity Health. 2015 Nov 14;14:131
pubmed: 26572127
BMC Public Health. 2016 Feb 03;16:115
pubmed: 26847554
Public Health. 2016 Aug;137:26-34
pubmed: 26869382
Int J Cardiol. 2016 Sep 1;218:275-283
pubmed: 27240151
Health Policy. 2016 Jul;120(7):833-9
pubmed: 27263063
Int J Biometeorol. 2017 Jan;61(1):127-135
pubmed: 27318999
J Public Health (Oxf). 2016 Dec 02;38(4):806-814
pubmed: 28158574
Oecologia. 1989 Jan;78(1):131-137
pubmed: 28311912
Int J Public Health. 2017 Nov;62(8):849-856
pubmed: 28361292
Euro Surveill. 2017 Apr 6;22(14):null
pubmed: 28424146
Int J Equity Health. 2017 Oct 25;16(1):184
pubmed: 29070050
Eur J Public Health. 2018 Jun 1;28(3):398-404
pubmed: 29452396
Int J Public Health. 2019 Jan;64(1):27-37
pubmed: 29577171
Lancet. 1997 May 10;349(9062):1341-6
pubmed: 9149695

Auteurs

Ricardo Almendra (R)

Centre of Studies in Geography and Spatial Planning, University of Coimbra, Coimbra, Portugal. Ricardoalmendra85@gmail.com.

Julian Perelman (J)

Escola Nacional de Saúde Pública, Universidade Nova de Lisboa, Lisbon, Portugal.

Joao Vasconcelos (J)

Polytechnic Institute of Leiria, IGOT/CEG Universidade de Lisboa, Lisbon, Portugal.

Paula Santana (P)

Centre of Studies on Geography and Spatial Planning, Department of Geography, University of Coimbra, Coimbra, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH